Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children
Clinical trial NCT00311415 · COMPLETED
Trial details
- NCT number
- NCT00311415
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2008-04-01
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.